Emyria Ltd (ASX: EMD) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Emyria Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $18.81 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 408.99 million
Earnings per share -0.036
Dividend per share N/A
Year To Date Return -11.54%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Emyria Ltd (ASX: EMD)
    Latest News

    Falling cannabis asx share price represented by cannabis leaves on a declining line graph
    Share Market News

    Cann (ASX:CAN) share price slides despite collaboration news

    The Cann Group Ltd (ASX:CAN) share price is sliding today despite news of a collaboration to fast track the approval…

    Read more »

    Five stacked building blocks with green arrows, indicating rising inflation or share prices
    Share Market News

    Why the Emyria (ASX:EMD) share price is climbing 7% higher today

    The Emyria Ltd (ASX: EMD) share price is climbing following a positive announcement to service its growing demand. We take…

    Read more »

    Share Market News

    Emyria (ASX:EMD) share price up 131% this month. Here's why

    The Emyria Ltd (ASX: EMD) share price has been one of the best performers over the month, rising an astonishing…

    Read more »

    Share Market News

    Why the Emyria (ASX:EMD) share price is seesawing today

    The Emyria Ltd (ASX: EMD) share price is see-sawing today despite the company winning a digital health monitoring grant. We…

    Read more »

    cannabis leaves on a rising line graph representing growth of ASX cannabis share price
    Share Market News

    Emerald Clinics share price soars 30% on new record

    The Emerald Clinics share price has surged nearly 30% in early trade following an expansion announcement from the company today.

    Read more »

    EMD ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Emyria Ltd

    Emyria Ltd operates a network of specialist medical clinics and uses purpose-built software and technology to gather clinical data from consenting patients. It operates in one segment of research and development.

    EMD Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    19 Jul 2024 $0.05 $0.00 0.00% 107,020 $0.05 $0.05 $0.05
    18 Jul 2024 $0.05 $0.00 0.00% 339,785 $0.05 $0.05 $0.05
    17 Jul 2024 $0.05 $0.00 0.00% 137,550 $0.05 $0.05 $0.05
    16 Jul 2024 $0.05 $0.00 0.00% 235,790 $0.05 $0.05 $0.05
    15 Jul 2024 $0.05 $0.00 0.00% 354,256 $0.05 $0.05 $0.05
    12 Jul 2024 $0.05 $0.00 0.00% 87,700 $0.05 $0.05 $0.05
    11 Jul 2024 $0.05 $0.00 0.00% 101,669 $0.05 $0.06 $0.05
    10 Jul 2024 $0.05 $0.00 0.00% 213,117 $0.05 $0.05 $0.05
    09 Jul 2024 $0.05 $0.00 0.00% 42,514 $0.06 $0.06 $0.05
    08 Jul 2024 $0.06 $0.00 0.00% 304,233 $0.06 $0.06 $0.05
    05 Jul 2024 $0.06 $0.00 0.00% 274,407 $0.06 $0.06 $0.05
    04 Jul 2024 $0.06 $0.00 0.00% 73,267 $0.06 $0.06 $0.06
    03 Jul 2024 $0.05 $0.00 0.00% 480,410 $0.05 $0.06 $0.05
    02 Jul 2024 $0.05 $0.01 21.74% 994,603 $0.05 $0.05 $0.04
    01 Jul 2024 $0.05 $0.00 0.00% 133,877 $0.04 $0.05 $0.04
    28 Jun 2024 $0.04 $0.00 0.00% 587,834 $0.04 $0.04 $0.04
    27 Jun 2024 $0.04 $0.00 0.00% 461,324 $0.04 $0.05 $0.04
    26 Jun 2024 $0.04 $0.00 0.00% 427,162 $0.05 $0.05 $0.04
    25 Jun 2024 $0.04 $0.00 0.00% 107,983 $0.04 $0.04 $0.04
    24 Jun 2024 $0.04 $0.00 0.00% 701,471 $0.04 $0.04 $0.04
    21 Jun 2024 $0.04 $0.00 0.00% 721,806 $0.05 $0.05 $0.04
    20 Jun 2024 $0.05 $0.00 0.00% 194,404 $0.05 $0.05 $0.05

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    22 Dec 2023 Michael Winlo Buy 100,000 $5,070
    On-market trade.
    09 Oct 2023 Alistair Vickery Buy 32,456 $2,255
    On-market trade.
    05 Oct 2023 Alistair Vickery Issued 18,519 $1,388
    Rights issue.
    05 Oct 2023 Alistair Vickery Issued 32,456 $2,434
    Rights issue.
    05 Oct 2023 Alistair Vickery Issued 25,488 $1,758
    Rights issue. As per announcement on 10-10-2023
    05 Oct 2023 Stewart Washer Issued 666,666 $45,999
    Rights issue. As per announcement on 10-10-2023
    05 Oct 2023 Stewart Washer Issued 1,333,333 $99,999
    Rights issue.
    05 Oct 2023 Michael Winlo Issued 32,148 $2,218
    Rights issue. As per announcement on 10-10-2023
    05 Oct 2023 Michael Winlo Issued 64,297 $4,822
    Rights issue.
    09 Aug 2023 Alistair Vickery Buy 115,418 $10,849
    On-market trade. http://www.aspecthuntley.com.au/asxdata/20231010/pdf/02723469.pdf
    09 Aug 2023 Stewart Washer Buy 225,000 $21,240
    On-market trade.
    08 Aug 2023 Michael Winlo Buy 200,000 $19,200
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Sir John Tooke Non-Executive Director Feb 2020
    Sir Tooke is Executive Chairman of Academic Health Solutions, a start-up Group offering advice to clients internationally on medical research and health service transformation. He is Senior Independent Director at BUPA Chile and was until 2019 non-executive director of the BUPA main Board and the Chair of the Medical Advisory Council. Mr Tooke is also a member of Risk Committee.
    Dr Michael Winlo Managing Director Nov 2019
    Dr Winlo was CEO at Linear Clinical Research Ltd (Linear) until October 2019, a company that provides clinical trial services for US and Asia-based biotech companies. Linear adopt electronic data capture technology. Dr Winlo retains a Directorship at Linear.
    Dr Karen Smith Non-Executive Director Nov 2021
    Dr Smith has overseen more than 100 clinical trials and more than 20 regulatory approvals leading to product launches across diverse therapeutic areas including neuroscience, rare disease, oncology, cardiology, dermatology, oncology and anti-infectives. In addition to R&D and pipeline development, her experience includes the acquisition of U.S. and international companies, divestitures and negotiating partnership deals between biotech and pharma. Dr Smith was recently Chief Medical Officer of Emergent BioSolutions.
    Dr Mohit Kaushal Non-Executive Director Aug 2023
    Dr KaushaL has also been appointed to the FDASIA Workgroup of the Health IT Policy Committee and to the National Committee on Vital and Health Statistics, advising HHS on Data Access and Use.
    Mr Greg Hutchinson Non-Executive Director Nov 2023
    --
    Ms Susan Patricia Park Company Secretary Mar 2023
    -
    Susan Patricia Park Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Dr Stewart James Washer & Dr Patrizia Derna Washer <The Washer Family A/C> 29,950,599 9.71%
    HSBC Custody Nominees (Australia) Limited 24,157,615 7.83%
    Mr Craig Lawrence Darby <Craig Lawrence Darby A/C> 21,109,790 6.85%
    Mal Washer Nominees Pty Ltd <Mal Washer Nominees Pty Ltd> 19,600,000 6.36%
    Mercator Shipwrights Pty Ltd <Mecator A/C> 19,600,000 6.36%
    Mr Sufian Ahmad <Sixty Two Capital A/C> 15,831,766 5.13%
    Mr Pak Lim Kong 6,766,667 2.19%
    Kobala Investments Pty Ltd <Fernando Edward Family A/C> 5,731,960 2.08%
    Mr Stephen Peter Somerville 4,900,000 1.59%
    Mr Bilal Ahmad 3,500,000 1.14%
    Citicorp Nominees Pty Limited 2,872,392 0.93%
    Lakewest Pty Ltd <Raymond Desmond Family A/C> 2,190,000 0.71%
    Mr Hakan Sahin &Mr Gursel Daniskan <Strategic Super A/C> 2,190,000 0.71%
    Mr Steve John Benrnard Grimley 2,166,304 0.70%
    Woodlands Opportunity Fund Pty Ltd 2,031,221 0.66%
    Adam James <Araucaria A/C> 1,960,000 0.64%
    D Schecter Medicine Professional Corporation 1,960,000 0.64%
    Miss Sihong Zeng 1,821,376 0.59%
    Canopy Growth Corporation 1,562,500 0.51%
    Mr Ahmed Noman 1,560,847 0.51%
    Mr Fadi Diab 1,552,941 0.50%
    Mr Dean Brett Blankfield 1,540,177 0.50%

    Profile

    since

    Note